Calistoga Pharmaceuticals Company Profile

Aggregated data from the web about Calistoga Pharmaceuticals

Company Name	Calistoga Pharmaceuticals
Website	www.frazierhealthcare.com
Snippet	Calistoga was founded in 2006 to develop the first selective inhibitor of PI3K-delta, a critical signaling molecule for many types of hematologic cancers. Calistoga's outstanding team brought the company's lead asset (then called CAL-101) into clinical studies and immediately achieved remarkable early activity in patients with chronic lymphocytic leukemia (CLL) and follicular lymphoma (FL).
Country	united states
Founded	2006.0
Website	calistogapharma.com
Industry	biotechnology
linkedin	linkedin.com/company/calistoga-pharmaceuticals
size_range	1 - 10
display_url	calistogapharma.com
Headquarters	seattle, washington, united states
Number of employees	5

Have a list of company names and need to update information? Use our Company Search tool.

Please note that Powrbot Inc does not own this content and cannot vouch for its accuracy, we simply aggregate public information for ease of research.

Want to update this profile? Please contact us here with a link to the public source verifying the edit.